Skip to main content
Equibles
CAMP logo

CAMP · Camp4 Therapeutics Corp · Metrics

Track CAMP — free

Use CAMP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CAMP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.33 -0.07 (-1.59%) At close · Sep 9
Russell 2000 member Rebalance outlook locked
Market Cap
$277.37M
Shares
62.75M

CAMP metrics

60 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.33
Market cap
$277.37M

Price action

20 metrics
Price change (1W)
+16.1%
Price change (30D)
+4.3%
Price change (3M)
+9.7%
Price change (6M)
-27.3%
Price change (YTD)
-28.2%
Price change (1Y)
+166.7%
Trailing year
Price change (5Y)
—
52-week high
$7.13
52-week low
$1.65
Change from 52-week high
-38.3%
Change from 52-week low
+166.7%
Annualized volatility
124.4%
Annualized volatility (3M)
100.8%
Beta
1.9
RSI (14D)
53.3
Price vs SMA 50
+6.6%
Price vs SMA 200
-1.9%
Avg volume (3M)
281,761
Relative volume
1.0
Average dollar volume
$1.19M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
62.75M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
65.8×
reciprocal yield 1.5%
P / book
—
FCF yield
-10.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-38.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-11-21

Profitability

9 metrics
Gross margin
—
Operating margin
-1,254.2%
Trailing 12 months
Net margin
-2,543.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$52.88M
Net income (TTM)
−$107.24M
Trailing 12 months
Diluted EPS (TTM)
$-2.31
FCF margin
-681.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.92

Growth

11 metrics
Revenue growth YoY
+18.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$4.22M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+187.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-114.8%
Debt / equity
—
Current ratio
4.7
EBITDA (TTM)
−$51.04M
Free cash flow (TTM)
−$28.72M
Quick ratio
4.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$86.40M
Latest balance sheet
Cash & equivalents
$86.40M
Total assets
$93.43M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$28.59M
Capital expenditures (TTM)
$129,000
R&D (TTM)
$38.69M
SG&A (TTM)
—
Stock compensation (TTM)
$5.54M
R&D / revenue
917.7%
Stock compensation / revenue
131.4%

Ownership (13F)

3 metrics
13F filers
61
13F filer change QoQ
+14
Institutional ownership
66.4%

Short interest

3 metrics
Short interest
2.0%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.40M
Insider-sentiment score
39 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1736730 CUSIP 13463J101 13F (30d) 45 filings 45 filers Visit website Investor relations